Autism Strategy Layer

• 1 in 31 children in the U.S. (approx. 3.2%) were identified with autism spectrum disorder (ASD) in 2022, a significant increase from 1 in 150 in 2000.
• 60% of patients with complex conditions like autism live in isolation, navigating a "minefield" of information with little professional coordination.
• 90 days typically pass between specialist appointments, leaving a massive data void where "invisible" behavioral or physiological declines go unnoticed.
• Fragmented Documentation: Care is currently split between school-based special education, private therapists (ABA, speech, occupational), and home life, with no shared operating layer to track progress or triggers.

The value of CareHub’s framework is in translating intermittent clinical logic into a shared, daily surveillance layer.

Diagnostic Triage

Monitoring relies on standardized tools like GARS-3, ADOS, and SRS, which track social communication and repetitive behaviors.

Structured Surveillance Priorities

• Communication Dynamics: Tracking the transition from non-speaking to functional communication.
• Co-occurring Medical Burden: Surveillance for epilepsy (10% of cases), GI issues (3x higher prevalence), and sleep disorders (affecting 2/3 of children).
• Medication Safety: Monitoring side effects of FDA-approved antipsychotics (risperidone, aripiprazole), which include significant weight gain and metabolic syndrome risk.

Medication Safety Example: Risperidone

For patients prescribed risperidone—an atypical antipsychotic used to treat irritability, aggression, and self-injurious behaviors in some autistic individuals—tracking metabolic and related signals is critical due to the drug’s side-effect profile.

• Weight Gain and Appetite: Risperidone is frequently associated with increased appetite and significant weight gain.
• Metabolic Syndrome Risk: Broader metabolic surveillance typically includes tracking glucose trends to identify diabetic instability or metabolic shifts.
• Hyperprolactinemia (Clinical Collaboration): Caregivers don’t monitor prolactin levels directly at home. Instead, they log adverse-effect signals as part of a collaborative framework with clinicians, who can confirm trends via labs when indicated.
• Extrapyramidal Symptoms: Acute movement-related side effects should be logged and reviewed with the prescribing team.

Psychoactive prescribing is common in pediatric autism care, and specialist visits can be spaced far apart. A shared operating layer helps families and clinicians bridge that between-visit data void so therapeutic benefits can be weighed continuously against metabolic and adverse-effect burden.

Medication Safety Example: Aripiprazole

Aripiprazole is another atypical antipsychotic used in some autism-care plans to support irritability-related behaviors. CareHub’s role is not to replace clinical judgment, but to help caregivers log observable changes consistently so clinicians can review trends between visits.

• Weight and Appetite: Track steady changes over weeks to understand side-effect burden and whether appetite is drifting upward.
• Activation / Restlessness Signals: New pacing, agitation, or an inability to sit still can indicate medication intolerance and should be captured as a time-stamped observation for the prescribing team.
• Sedation or Sleep Disruption: Log daytime sleepiness, bedtime resistance, and sleep fragmentation, especially when medication timing changes.
• Movement-Related Side Effects: Document tremor, stiffness, unusual facial movements, or other extrapyramidal-type symptoms for clinical review.
• Metabolic Monitoring (Clinician-Reviewed): Pair home logs with periodic clinician-directed metabolic checks when indicated, so risk signals don’t get lost across 90-day appointment gaps.

Care coordination is the first layer; the next is helping caregivers respond to behavioral escalation before reaching a crisis point.

• Behavioral Signals: Stimming, pacing, and repetitive questions are often pre-meltdown indicators.
• Silent Illness Presentation: In non-verbal individuals, sudden agitation or self-injury (SIB) may be the only signal of underlying pain, constipation, or dehydration.
• Non-Pharmacological Support: Integrating routines for music therapy, sensory integration, and ABA-based behavioral rewards can stabilize the home environment.

The existing Next.js app’s tracker stack already covers core physiological signals, but an Autism-specific layer must extend these operational surfaces.

Care Domain	Current Calendar Surfaces	Autism-Specific Layer Additions
Physiological Stability	Temp, Pulse, SpO2	Seizure Log: Frequency and duration.
Nutrition & GI	Eat, Drink, GI, Weight	Calcium/Vit D Tracker: Essential for those on elimination (casein-free) diets.
Sleep & Neurological	Sleep hours/quality	Melatonin Response: Tracking efficacy in refractory insomnia.
Behavior & Mood	Mental Health journal	Meltdown/Shutdown Log: Triggers and duration.
Medication Safety	Drugs, Interactions	Metabolic Side Effects: Weight/appetite trends and glucose/metabolic-shift flags. Also log prolactin-related adverse-effect signals (clinician-confirmed) and extrapyramidal symptoms for clinical review.
Social/Functional	Movement	Stimming & SIB: Frequency of repetitive or self-injurious acts.

The global autism market is shaped by a significant and rising prevalence of autism spectrum disorder (ASD). Globally, ASD affects approximately 1 in 100 children. In the United States, 2022 data identifies a higher rate of 1 in 31 children, representing a dramatic increase from 1 in 150 in 2000.

This growing demographic creates a major economic impact, exerting immense costs on healthcare systems and causing substantial lost productivity—especially when adult support needs remain unmet.

Market Segments

• Clinical Interventions: Demand is high for Applied Behavior Analysis (ABA), speech-language pathology, and occupational therapy.
• Pharmacological Sector: Over half of autistic children in the U.S. use psychoactive drugs such as risperidone or aripiprazole to manage co-occurring symptoms, creating ongoing demand for medication safety monitoring and shared documentation.
• Adult Transition Services: Since approximately 85% of autistic adults require support for independent living, there is an expanding market for vocational coaching and home-based support services.
• Home Support Services: In-home care and respite services are delivered through non-profits, for-profit providers, and public agencies (including Medicaid-funded services in the U.S.).

Technology as a Growth Driver

Social media platforms—particularly YouTube, Twitter, and Facebook—have become “minefields of knowledge transfer,” where caregivers and patients bypass professional silos to seek peer-led advice. This behavior signals demand for trusted, structured coordination tools that can reduce confusion and make trends easier to review.

Digital coordination platforms like CareHub are emerging to close the “care gap”—the 90-day data void between specialist appointments where invisible behavioral or physiological declines often go unnoticed.

Government Momentum

Governments are increasingly viewing early intervention as a necessary investment for the future. Effective early treatment (ideally between ages 1 and 3) can improve long-term autonomy and reduce the lifelong societal costs associated with non-independent adults. Federal initiatives like the CDC’s “Learn the Signs. Act Early.” program also reinforce developmental monitoring as a public health priority.

Market Sizing Note

Based on the provided sources, a specific total dollar figure for the current global market value of autism services is not stated here. In contrast, the related Alzheimer’s and dementia briefing cites elderly-care segments (nursing homes, home health, etc.) at approximately $1.2T globally in 2024—highlighting the scale of complex care coordination markets even when autism-specific totals are not enumerated in these materials.

Unlike solo-patient workflows, autism care requires a coordinated network.

• Primary Users: Parents or paid aides tracking on behalf of children or non-speaking adults.
• Network Contributors: A single patient’s data may be viewed/edited by a team of 3–5, including teachers, speech pathologists, and ABA technicians.
• Shared Operating Layer: CareHub provides one place to log school-to-home transitions, reducing the communication gaps that lead to caregiver burnout.

Current tools are often siloed (e.g., school-only software or clinical EHRs with no family portal).

• CareHub Advantage: Combines clinical-grade vitals tracking with decentralized privacy (no ID/Credit Card required) and AI-driven insights for non-pharmacological interventions.

• Federal Signal: Initiatives like "Learn the Signs. Act Early." emphasize that developmental monitoring (tracking) is a public health priority.
• Strategic Advantage: If CareHub connects to state-level Medicaid waivers (like the Arkansas 1915(c) program) or school district IEP workflows, it becomes durable care infrastructure.
• Project Initiative: David Lennard’s initiative focuses on "AI for Good," ensuring that the 116 native translations and decentralized architecture support a global, inclusive community.